Scribe uses CRISPR-based platforms to develop one-and-done genetic medicines that could one day head off cardiometabolic diseases and eliminate the need for years of costly and burdensome medical interventions.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,